-
-
Originally Posted by Joshuatree
Thanks for the link JT.
Hopefully the library will run another computer course this year...
Can copy announcements for emails,but can't get them on here.
-
Pay off could be pretty incredible if widely adopted across GPs, although that's obviously many years and several clinical trials away. People say that medicine moves fast but high technology can take a very long time to filter through unfortunately, even after the trials. Just another possible string in their bow - currently keeping more than busy enough with existing customers and applications.
-
Originally Posted by percy
Thanks for the link JT.
Hopefully the library will run another computer course this year...
Can copy announcements for emails,but can't get them on here.
So youve right clicked on the link, a window opens up with choices, and one left clicks on "copy link"
Then goes to sharetrader reply space, right clicks and window comes up, left click on "Paste "and presto.
PharmaZen_half_year_result_2019_USX.pdf
Last edited by Joshuatree; 15-01-2020 at 04:17 PM.
-
Last edited by percy; 15-01-2020 at 05:14 PM.
-
Member
Good to see Prof. Kate McGrath appointed Independent Director. She is currently Deputy Vice-Chancellor of University of Technology Sydney. Previously had senior appointments at Victoria University, MacDiamard Institute, and Callaghan Innovation.
And interesting to see Syft Technlogies units are being used in cancer detection research by Imperial College London, Otago University, and Callaghan Institution. Early days, but good to see the advancement of this technology into the medical sphere.
It is all progress.
-
[QUOTE=percy;785843]SIFT-MS technology drives simplification of bowel cancer screening
15 January 2020 Press Release
Firm: Syft Technologies Limited
Security: Syft Tech Ords
Documents:
Syft_bowel_cancer_trials.pdf
This should be very interesting.Warning it will take years,but I don't think anyone will miss having a colonoscopy.?[/QU
Interesting timing after issuing those shares for something that has being trialed for 2 years
-
Interesting timing after issuing those shares for something that has being trialed for 2 years
-
Member
SYFT Quarterly Newsletter shows further progress. The FY result soon - hopefully will be very good news.
-
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks